Analysis of gene expression changes upon topobexin treatment and TOP2B-knockout in hiPSC-derived cardiomyocytes

Veronika Kerestes, Ian Cowell, Anna Jirkovska, Mushtaq Khazeem, Galina Karabanovich, Iuliia Melnikova, John Casement, Jan Kubes, Tomas Simunek, Jaroslav Roh, Matthew Schellenberg, Adam Creigh, Chunbo Yang, Majlinda Lako, Lyle Armstrong, Caroline Austin · 2026

Read Analysis of gene expression changes upon topobexin treatment and TOP2B-knockout in hiPSC-derived cardiomyocytes by Veronika Kerestes, Ian Cowell, Anna Jirkovska, Mushtaq Khazeem, Galina Karabanovich, Iuliia Melnikova, John Casement, Jan Kubes, Tomas Simunek, Jaroslav Roh, Matthew Schellenberg, Adam Creigh, Chunbo Yang, Majlinda Lako, Lyle Armstrong, Caroline Austin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13552481.txt.

Description

The role of DNA topoisomerase II beta (TOP2B) in cardiomyocyte differentiation is poorly understood. To address this, human induced pluripotent stem cells (hiPSC) were differentiated into cardiomyocytes (CM) that were wild type (WT) or contained a genomic deletion of Topoisomerase 2B (BKO). Both WT and BKO hiPSC could be induced to differentiate into sheets of beating cardiomyocytes.

Catalog record

CREATORVeronika Kerestes, Ian Cowell, Anna Jirkovska, Mushtaq Khazeem, Galina Karabanovich, Iuliia Melnikova, John Casement, Jan Kubes, Tomas Simunek, Jaroslav Roh, Matthew Schellenberg, Adam Creigh, Chunbo Yang, Majlinda Lako, Lyle Armstrong, Caroline Austin
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE34 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13552481

Browse the full library · About the Tower of Babel